Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07526870) titled 'Intradermal Microbotulinum Toxin for Sebum Reduction and Facial Pore Improvement' on April 3.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Instituto de Oftalmologia Fundación Conde de Valenciana
Condition:
Facial Aging
Facial Wrinkles and Rhytides Reduction
Intervention:
Drug: Botulinum Toxin Type A (Dysport(R))
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: July 24, 2024
Target Sample Size: 30
Countries of Recruitment:
Mexico
To know more, v...